Patent · US Active

Compounds and methods for the modulation of COMP

US10287584B2 · kind B2 · utility

0Cited by
25References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 12, 2015
Grant dateMay 14, 2019
Priority date
Expiry dateNov 12, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell. In certain embodiments, the target nucleic acid is a nucleic acid that encodes cartilage oligomeric matrix protein. In certain embodiments, the target nucleic acid is a nucleic acid expressed in the growth plate, tendon, or cartilage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.